Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteins

Random mutagenesis of human papillomavirus type 16 (HPV16) E1 was used to generate E1 missense mutants defective for interaction with either hUBC9 or 16E1-BP, two cDNAs encoding proteins that have been identified by their ability to interact with HPV16 E1 in two-hybrid assays. hUBC9, the human counterpart of Saccharomyces cerevisiae UBC9, is a ubiquitin-conjugating enzyme known to be involved in cell cycle progression. 16E1-BP encodes a protein of no known function but does contain an ATPase signature motif. Eight hUBC9 or 16E1-BP interaction-defective HPV16 E1 missense mutants were identified and characterized for origin-dependent transient DNA replication, ATPase activity, and various protein-protein interaction phenotypes. Six of these mutant E1 proteins were significantly impaired for replication. Among these, two classes of replication-defective HPV16 E1 missense mutants were observed. One class, represented by the S330R replication-defective mutant (containing an S-to-R change at position 330), remained competent for all protein-protein interactions tested, with the exception of hUBC9 association. Furthermore, this mutant, unlike the other replication-defective HPV16 E1 missense mutants, had a strong dominant negative replication phenotype in transient-replication assays. The other class, represented by five of the missense mutants, was defective for multiple protein-protein interactions, usually including, but not limited to, the interaction defect for which each mutant was originally selected. In many cases, a single missense mutation in one region of HPV16 E1 had pleiotropic effects, even upon activities thought to be associated with other domains of HPV16 E1. This suggests that E1 proteins are not modular but may instead be composed of multiple structurally and/or functionally interdependent domains.

[1]  J. D. Benson,et al.  Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins , 1997, Journal of virology.

[2]  M. Blondel,et al.  G2 cyclins are required for the degradation of G1 cyclins in yeast , 1996, Nature.

[3]  S. Jentsch,et al.  mUBC9, a Novel Adenovirus E1A-interacting Protein That Complements a Yeast Cell Cycle Defect* , 1996, The Journal of Biological Chemistry.

[4]  W. Seufert,et al.  A Yeast Ubc9 Mutant Protein with Temperature-sensitive in Vivo Function Is Subject to Conditional Proteolysis by a Ubiquitin- and Proteasome-dependent Pathway* , 1996, The Journal of Biological Chemistry.

[5]  J. Testa,et al.  Molecular Cloning of the cDNA and Chromosome Localization of the Gene for Human Ubiquitin-conjugating Enzyme 9* , 1996, The Journal of Biological Chemistry.

[6]  M. Vidal,et al.  Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Vidal,et al.  Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Stenlund,et al.  The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring‐like structure. , 1996, The EMBO journal.

[9]  D. Earnshaw,et al.  Characterization of the helicase and ATPase activity of human papillomavirus type 6b E1 protein. , 1996, The Journal of general virology.

[10]  P. Howley,et al.  Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. , 1996, Nucleic acids research.

[11]  M. Westerman,et al.  Perturbation of the host cell cycle and DNA replication by the bovine papillomavirus replication protein E1. , 1996, Virology.

[12]  D. Ward,et al.  Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Evans,et al.  Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor , 1996, Steroids.

[14]  J. D. Benson,et al.  Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions , 1996, Journal of virology.

[15]  Y. Koltin,et al.  Two-hybrid interaction of a human UBC9 homolog with centromere proteins of , 1996 .

[16]  A. Stenlund,et al.  Cellular factors required for papillomavirus DNA replication , 1995, Journal of virology.

[17]  A. Stenlund,et al.  Co‐operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. , 1995, The EMBO journal.

[18]  M. Stanley,et al.  The ATP-binding and ATPase activities of human papillomavirus type 16 E1 are significantly weakened by the absence of prolines in its ATP-binding domain. , 1995, The Journal of general virology.

[19]  V. Wilson,et al.  BPV E1 protein alters the kinetics of cell cycle entry of serum starved mouse fibroblasts. , 1995, Cytometry.

[20]  J. D. Benson,et al.  Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation , 1995, Journal of virology.

[21]  C. Bonne-Andrea,et al.  Bovine papillomavirus E1 protein can, by itself, efficiently drive multiple rounds of DNA synthesis in vitro , 1995, Journal of virology.

[22]  C. Bonne-Andrea,et al.  Bovine papillomavirus E1 protein binds specifically DNA polymerase alpha but not replication protein A , 1995, Journal of virology.

[23]  R. Brent,et al.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.

[24]  Bruce Futcher,et al.  Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins , 1995, Nature.

[25]  V. Gopalakrishnan,et al.  E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Gillette,et al.  Induction of structural changes in the bovine papillomavirus type 1 origin of replication by the viral E1 and E2 proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Hurwitz,et al.  The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Feldmann,et al.  Identification of a set of yeast genes coding for a novel family of putative ATPases with high similarity to constituents of the 26S protease complex , 1994, Yeast.

[29]  M. Botchan,et al.  The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Hurwitz,et al.  Replication of bovine papillomavirus type 1 origin-containing DNA in crude extracts and with purified proteins. , 1994, The Journal of biological chemistry.

[31]  M. DePamphilis,et al.  Papillomavirus contains cis-acting sequences that can suppress but not regulate origins of DNA replication , 1994, Journal of virology.

[32]  M. Yaniv,et al.  The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2 , 1994, Journal of virology.

[33]  S. Khan,et al.  Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins , 1994, Journal of virology.

[34]  A. V. D. Eb,et al.  INTRODUCTION OF DNA INTO MAMMALIAN CELLS , 1994 .

[35]  M A Romanos,et al.  E1 protein of human papillomavirus is a DNA helicase/ATPase. , 1993, Nucleic acids research.

[36]  M. Botchan,et al.  DNA-binding domain of bovine papillomavirus type 1 E1 helicase: structural and functional aspects , 1993, Journal of virology.

[37]  S. V. Vande Pol,et al.  Repression of bovine papillomavirus type 1 transcription by the E1 replication protein , 1993, Journal of virology.

[38]  J. Hurwitz,et al.  Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. , 1993, The Journal of biological chemistry.

[39]  M. Botchan,et al.  The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Hurwitz,et al.  Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Botchan,et al.  The E1 replication protein of bovine papillomavirus type 1 contains an extended nuclear localization signal that includes a p34cdc2 phosphorylation site , 1993, Journal of virology.

[42]  J. Hurwitz,et al.  Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Monini,et al.  Activation of eukaryotic transcriptional promoters by the bovine papillomavirus E1-replication factor. , 1993, Intervirology.

[44]  P. Howley,et al.  Transient replication of human papillomavirus DNAs , 1992, Journal of virology.

[45]  Peggy J. Farnham,et al.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties , 1992, Cell.

[46]  C. Cole,et al.  Mechanisms of interference with simian virus 40 (SV40) DNA replication by trans-dominant mutants of SV40 large T antigen , 1992, Journal of virology.

[47]  P. Howley,et al.  Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Botchan,et al.  Activation of BPV-1 replication in vitro by the transcription factor E2 , 1991, Nature.

[49]  M. Lusky,et al.  Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Ustav,et al.  Transient replication of BPV‐1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. , 1991, The EMBO journal.

[51]  L. Laimins,et al.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro , 1991, Journal of virology.

[52]  M. Botchan,et al.  Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. , 1990, Science.

[53]  I. Herskowitz Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[54]  D. Nathans,et al.  trans-dominant defective mutants of simian virus 40 T antigen , 1987, Journal of virology.

[55]  I. Seif,et al.  A common function for polyoma virus large-T and papillomavirus E1 proteins? , 1984, Nature.

[56]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[57]  B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures. , 1967, Journal of molecular biology.